Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;142(5):511-516.
doi: 10.1111/ane.13288. Epub 2020 Jun 5.

Upregulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients

Mattia Zanoni  1 , Elisa Orlandi  2 , Giulia Rossetti  2 , Marco Turatti  1 , Massimiliano Calabrese  1 , Macarena Gomez Lira  2 , Alberto Gajofatto  1
Affiliations

Upregulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients

Mattia Zanoni et al. Acta Neurol Scand. 2020 Nov.

Abstract

Background: Circulating microRNAs have emerged as novel multiple sclerosis (MS) biomarkers.

Aims: To assess the association between candidate miR expression in serum samples of patients with MS and the disease course.

Methods: Serum levels of ten microRNAs (ie, miR-199, miR-128-3p, miR-20a-5p, miR-27a-3p, miR-15b-5p, miR-325, miR-92a1-5p, miR-223-5p, miR-22-5p, and miR-23a-5p) were measured in 74 MS cases and 17 non-MS controls consecutively enrolled at Verona University Hospital. The association of microRNA expression with patients' clinical and MRI features was analyzed. Candidate microRNAs were detected by real-time PCR and expressed as ratio of each microRNA level to a normalizer.

Results: Serum miR-128-3p levels were higher in progressive than relapsing MS (median ratio 2.86 vs 0.73, P = .036). In addition, miR-128-3p was upregulated in patients without relapses after sample collection compared to cases who relapsed (1.64 vs 0.82; P = .014). miR-128-3p levels and relapse rate were inversely correlated (r = -.44, P = .008).

Conclusions: Serum levels of mir-128-3p could be related to biological mechanisms underlying MS activity and progression.

Keywords: biomarker; microRNA; multiple sclerosis.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Curtale G. MiRNAs at the crossroads between innate immunity and cancer: focus on macrophages. Cells. 2018;7(2):12.
    1. Huang Q, Xiao B, Ma X, et al. MicroRNAs associated with the pathogenesis of multiple sclerosis. J Neuroimmunol. 2016;295-296:148-161.
    1. Kacperska MJ, Jastrzebski K, Tomasik B, Walenczak J, Konarska-Krol M, Glabinski A. Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity-preliminary study. J Mol Neurosci. 2015;56(1):154-163.
    1. Fenoglio C, Ridolfi E, Cantoni C, et al. Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis. Mult. Scler. 2013;19:1938-1942.
    1. Keller A, Leidinger P, Lange J, et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One. 2009;4:e7440.

LinkOut - more resources